Beta amyloid peptides are short sequences of amino acids derived from the amyloid precursor protein (APP). These peptides are typically 36-43 amino acids long and are most commonly associated with their role in the pathology of Alzheimer's disease. The accumulation of beta amyloid peptides in the brain leads to the formation of amyloid plaques, which are a hallmark of this neurodegenerative disorder.